Mitre Medical

Mitre Medical is a private, clinical-stage medical device company founded in 2018 and headquartered in Menlo Park, California. The company is leveraging its expertise in epicardial, beating-heart therapies to develop devices that protect heart valves and ventricles, initially targeting mitral regurgitation and now focusing on the critical unmet need of preventing right heart failure in LVAD patients. With an experienced leadership team and a track record in cardiovascular device development, Mitre is positioned to address a significant complication in a high-risk patient population, though it faces the challenges typical of an early-stage device developer navigating clinical and regulatory pathways.

Minimally invasive, epicardial devices for ventricular reshaping and support, designed for beating-heart procedures that protect heart valves.

In the LVAD adjuvant space, competition is limited but includes optimized patient management, pharmacological support, and next-generation LVAD designs. For mitral repair, the market is highly competitive with numerous transcatheter and surgical solutions from large medtech players, though Mitre's beating-heart, epicardial approach is a differentiating niche.